Canadian Food and Drug Legislation & Commentary, 2021 Edition

Canada's Leading Compilation of Federal Food and Drug Laws
Food and drug legislation is a critical part of Canada's national regulatory framework. Consumers of foods, drugs, medical devices, and cosmetics look to this system to ensure that regulated products meet all health and safety standards. Thousands of professionals have a responsibility to interpret and apply the statutes and regulations in this extremely complex area of law.

Canadian Food and Drug Legislation & Commentary meets the research and reference needs of this growing group. This unique compilation includes the most up-to-date Food and Drugs Act and all related federal statutes and regulations. A detailed index further simplifies your research.

The commentary, prepared by Borden Ladner Gervais LLP, which has one of Canada's largest food and drugs practices, explains the legal framework and recent developments, and gives an overview of each part and division of the key legislation as follows:

• Food and Drugs Act and select regulations
• Consumer Packaging and Labelling Act and Regulations
• Controlled Drugs and Substances Act and Regulations
• Safe Food for Canadians Act and Regulations
• Cannabis Act and select regulations

Highlights of the 2021 Edition

• Updated commentary about recent legislative changes and federal government initiatives to increase consumer safety, understanding of food and drugs in the market, introducing new oversight of clinical trials, introducing a regulatory framework for advanced therapeutic products, and implementing new powers for inspectors
• All legislation fully updated, including recent amendments to:
  • The Food and Drugs Regulations, am. SOR/2021-45, SOR/2021-46
  • The Fees in Respect of Dealer’s Licences Regulations (SOR/2011-79) (formerly known as the Fees in Respect of Drugs and Medical Devices)
  • The Controlled Drugs and Substances Act, SOR/2021-044
  • The Narcotic Control Regulations, am. SOR/2021-043
• Establishment Licence Fees Remission Order (Indication of an Activity in respect of a COVID-19 Drug) (2019-124) am. SOR/2020-213

Features and Benefits

• Chart form summaries of key elements of legislation – Help you navigate the highly complex legislation and understand the technical terminology
• Appendix on references links – Direct you to extensive supplementary materials needed in daily practice, including the web sites of organizations, agencies, and various branches of the Federal government
• Full text of key legislation – Have all pertinent legislation at your fingertips

An Essential Reference Tool For:

• Biotech, pharmaceutical, and health lawyers who advise on all aspects of compliance with food and drug statutes and regulations
• Regulatory affairs consultants who assist manufacturers in regulated industries, including foods, pharmaceuticals, and medical devices, as well as natural health products, food additives, and cosmetics, with submission processes, guidelines, and requirements
• Corporate counsel and regulatory affairs personnel at food, pharmaceutical, biotechnology, medical device, and cosmetics companies who must ensure that product development, manufacturing, and marketing practices meet or exceed government requirements